For investors seeking out value opportunities the daily 'new lows' list is something of a must read and a hunting ground for potential investment opportunities.
Here are four stocks that are all trading near their 52-week lows that could be offering up appealing entry points for long-term investors.
1. Crown Resorts Ltd (ASX: CWN) was as recently as the start of this month languishing at fresh 52-week lows, however, over the past two weeks the stock has gained around 10%. The outlook for Crown is certainly murky considering its exposure to the unpredictable Macau market, however, its Australian and British-based casino businesses are much easier to forecast earnings for.
While the ultimate profitability of the group's foray into the Sydney casino market remains to be seen, investors might find the current share price offers good risk versus reward with limited downside considering the quality of the Melbourne, Perth and London assets and attractive upside potential.
2. Primary Health Care Limited (ASX: PRY) has been heavily sold down in the past year with the stock languishing at a 52-week low.
The company's reliance on government medicare payments for its revenue is obviously a concern for many investors however the regularity of its client base and growth initiatives such as a move into IVF services, could make this multi-year low a buying opportunity.
3. Infomedia Limited's (ASX: IFM) share price arguably got well ahead of itself with investors placing the stock on a high multiple in anticipation of high growth rates. With management providing guidance for high-single digit to low-double digit revenue growth in financial year 2016 the market has responded by selling the stock down.
Arguably the sell-off (which saw the stock recently hit a new 52-week low) has taken the stock back to levels which could be considered an appealing buying opportunity.
4. For legal services firm Shine Corporate Ltd (ASX: SHJ), the main cause of the fall in its share price to a new 52-week low has likely been flow over concerns surrounding its larger listed peer Slater & Gordon Limited (ASX: SGH).
While there is some overlap in terms of accounting and reporting procedures, the primary concern of investors with regards to Slater & Gordon is its large UK acquisition – an issue which doesn't affect Shine. For investors who missed the opportunity to acquire Shine in its initial public offering in 2013 or soon afterwards, now could be their opportunity.
